1. Home
  2. AWF vs DNA Comparison

AWF vs DNA Comparison

Compare AWF & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

N/A

Current Price

$9.58

Market Cap

868.3M

Sector

Finance

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$9.54

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AWF
DNA
Founded
1993
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
868.3M
835.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AWF
DNA
Price
$9.58
$9.54
Analyst Decision
Sell
Analyst Count
0
3
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
461.7K
★ 2.5M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 7.57%
N/A
EPS Growth
N/A
★ 46.49
EPS
★ N/A
N/A
Revenue
N/A
★ $170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.41
$5.37
52 Week High
$10.87
$18.22

Technical Indicators

Market Signals
Indicator
AWF
DNA
Relative Strength Index (RSI) 47.16 44.51
Support Level $9.42 $9.15
Resistance Level $9.64 $10.34
Average True Range (ATR) 0.08 1.59
MACD 0.01 -0.20
Stochastic Oscillator 37.50 5.65

Price Performance

Historical Comparison
AWF
DNA

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: